Sree Rayalaseema posts 7.6% profit rise in Q1FY26
Sree Rayalaseema Hi-Strength Hypo Limited posted strong Q1FY26 results with standalone net profit rising 7.6% to ₹251.7 crore and revenue growing 17% to ₹2,109.5 crore. Consolidated metrics showed similar strength. The company continues to defend against a USD 13.17 million breach of contract claim by Maersk Shipping Line, having secured interim protections in Indian courts.

*this image is generated using AI for illustrative purposes only.
Sree Rayalaseema Hi-Strength Hypo Limited reported a 7.6% increase in standalone net profit to ₹251.7 crore for the first quarter of FY26, ending June 30, 2026. The chemical manufacturer’s revenue from operations rose 17% year-on-year to ₹2,109.5 crore, reflecting stronger demand and operational efficiency. Consolidated net profit attributable to owners grew 8.9% to ₹249.6 crore, while consolidated revenue remained stable at ₹2,109.5 crore due to minor adjustments in other income.
The Board of Directors approved the unaudited financial results on August 12, 2026, in compliance with Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. S.T. Mohite & Co., Chartered Accountants, issued a limited review report confirming that the statements comply with Indian Accounting Standards (Ind AS) and contain no material misstatements. The company continues to report only one operating segment—Chemicals—as wind energy power contributes less than 10% of total revenue.
Financial Performance Highlights
| Metric | Standalone Q1FY26 | Standalone Q1FY25 | Change | Consolidated Q1FY26 | Consolidated Q1FY25 | Change |
|---|---|---|---|---|---|---|
| Revenue from Operations (₹ Cr) | 2,109.46 | 1,802.55 | +17.0% | 2,109.46 | 1,802.55 | +17.0% |
| Total Revenue (₹ Cr) | 2,208.28 | 1,906.60 | +15.8% | 2,208.11 | 1,906.43 | +15.8% |
| Net Profit After Tax (₹ Cr) | 251.72 | 234.10 | +7.5% | 247.30 | 224.15 | +10.3% |
| Earnings Per Share (₹) | 14.66 | 13.64 | +7.5% | 14.54 | 13.35 | +8.9% |
Standalone earnings per share stood at ₹14.66, up from ₹13.64 in the corresponding quarter of FY25. The profit growth was supported by a reduction in exceptional items, which included a net loss of ₹35.0 crore from gold futures fair valuation at mark-to-market prices. This loss was partially offset by profits from other gold future contracts during the quarter.
What the Numbers Show
The divergence between revenue growth (17%) and net profit growth (7.5%) indicates margin pressure, likely stemming from higher cost of materials consumed, which rose to ₹1,139.9 crore from ₹983.7 crore in Q1FY25. However, the company managed to control employee benefits and finance costs, keeping them relatively stable. The significant rise in other comprehensive income, driven by a ₹516.4 crore gain on FVTOCI financial instruments, boosted total comprehensive income to ₹638.1 crore, highlighting the impact of investment performance on overall equity value.
Legal Proceedings Update
Sree Rayalaseema continues to face legal proceedings initiated by Maersk Shipping Line in the Business and Property Courts of England and Wales. The claimant seeks damages of USD 13,178,280.51 for alleged breaches of contract of carriage. The company disputes the claim and has secured interim reliefs from Indian courts, including an order restraining Maersk from pursuing foreign proceedings under the Hague Convention. Management stated that the ultimate financial liability remains undetermined as appropriate legal remedies are being pursued.
Historical Stock Returns for Sree Rayalaseema Hi-Strength Hypo
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +0.21% | +3.14% | +1.31% | +2.80% | -17.24% | +58.89% |
How might the 10% gap between revenue growth and net profit growth impact Sree Rayalaseema's valuation multiples compared to peers in the chemical sector?
What is the company's hedging strategy for raw material costs given the significant rise in materials consumed, and will this margin pressure persist in Q2FY26?
Could the substantial ₹516.4 crore gain on FVTOCI financial instruments indicate a strategic shift in capital allocation towards financial assets rather than core operational expansion?


































